| Year |
Citation |
Score |
| 2013 |
Glass C, Wuertzer C, Cui X, Bi Y, Davuluri R, Xiao YY, Wilson M, Owens K, Zhang Y, Perkins A. Global Identification of EVI1 Target Genes in Acute Myeloid Leukemia. Plos One. 8: e67134. PMID 23826213 DOI: 10.1371/Journal.Pone.0067134 |
0.305 |
|
| 2008 |
Wuertzer CA, Sullivan MA, Qiu X, Federoff HJ. CNS delivery of vectored prion-specific single-chain antibodies delays disease onset. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 481-6. PMID 18180775 DOI: 10.1038/Sj.Mt.6300387 |
0.609 |
|
| 2006 |
Maguire-Zeiss KA, Wang CI, Yehling E, Sullivan MA, Short DW, Su X, Gouzer G, Henricksen LA, Wuertzer CA, Federoff HJ. Identification of human alpha-synuclein specific single chain antibodies. Biochemical and Biophysical Research Communications. 349: 1198-205. PMID 16973126 DOI: 10.1016/J.Bbrc.2006.08.127 |
0.568 |
|
| 2006 |
Tyler CM, Wuertzer CA, Bowers WJ, Federoff HJ. HSV amplicons: neuro applications. Current Gene Therapy. 6: 337-50. PMID 16787185 DOI: 10.2174/156652306777592045 |
0.533 |
|
| 2005 |
Wuertzer CA, Sullivan MA, Federoff HJ. 966. AAV Delivered Single-Chain Antibodies as Passive Immuno-Therapy for Prion Disease Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.509 |
0.611 |
|
| 2004 |
Wuertzer CA, Sullivan MA, Federoff HJ. 552. Single-Chain Antibodies for Viral-Based Passive Immuno-Therapy for Prion Disease: Linear Epitope Mapping and Clearance from Thalamic Injection Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.471 |
0.598 |
|
| 2002 |
Richfield EK, Thiruchelvam MJ, Cory-Slechta DA, Wuertzer C, Gainetdinov RR, Caron MG, Di Monte DA, Federoff HJ. Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice. Experimental Neurology. 175: 35-48. PMID 12009758 DOI: 10.1006/Exnr.2002.7882 |
0.486 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2011 |
Zhang Y, Sicot G, Cui X, Vogel M, Wuertzer CA, Lezon-Geyda K, Wheeler J, Harki DA, Muzikar KA, Stolper DA, Dervan PB, Perkins AS. Targeting a DNA binding motif of the EVI1 protein by a pyrrole-imidazole polyamide. Biochemistry. 50: 10431-41. PMID 22039883 DOI: 10.1021/Bi200962U |
0.293 |
|
| 2013 |
Zhang Y, Cui X, Wuertzer CA, Perkins AS. EVI1, A Potential Regulator Of CEBPA; A Contributory Mechanism In Leukemogenesis? Blood. 122: 2495-2495. DOI: 10.1182/Blood.V122.21.2495.2495 |
0.266 |
|
| 2011 |
Zhang Y, Stehling-Sun S, Lezon-Geyda K, Juneja SC, Coillard L, Chatterjee G, Wuertzer CA, Camargo F, Perkins AS. PR-domain-containing Mds1-Evi1 is critical for long-term hematopoietic stem cell function. Blood. 118: 3853-61. PMID 21666053 DOI: 10.1182/Blood-2011-02-334680 |
0.255 |
|
| 2012 |
Cannon A, Yang B, Knight J, Farnham IM, Zhang Y, Wuertzer CA, D'Alton S, Lin WL, Castanedes-Casey M, Rousseau L, Scott B, Jurasic M, Howard J, Yu X, Bailey R, et al. Neuronal sensitivity to TDP-43 overexpression is dependent on timing of induction. Acta Neuropathologica. 123: 807-23. PMID 22539017 DOI: 10.1007/S00401-012-0979-3 |
0.217 |
|
| 2010 |
Ahmed Z, Sheng H, Xu YF, Lin WL, Innes AE, Gass J, Yu X, Wuertzer CA, Hou H, Chiba S, Yamanouchi K, Leissring M, Petrucelli L, Nishihara M, Hutton ML, et al. Accelerated lipofuscinosis and ubiquitination in granulin knockout mice suggest a role for progranulin in successful aging. The American Journal of Pathology. 177: 311-24. PMID 20522652 DOI: 10.2353/Ajpath.2010.090915 |
0.17 |
|
| 2010 |
Ahmed Z, Sheng H, Xu YF, Lin WL, Innes AE, Gass J, Yu X, Wuertzer CA, Hou H, Chiba S, Yamanouchi K, Leissring M, Petrucelli L, Nishihara M, Hutton ML, et al. Accelerated lipofuscinosis and ubiquitination in granulin knockout mice suggest a role for progranulin in successful aging (American Journal of Pathology (2010), 177, (311-324)) American Journal of Pathology. 177: 2146. DOI: 10.2353/Ajpath.2010.100772 |
0.102 |
|
| Hide low-probability matches. |